Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 10/20 | 0.71 |
| ▸ | PGR | P06401 | 7/20 | 0.71 |
| ▸ | AR | P10275 | 7/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.71 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.71 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.71 |
| ▸ | MAPT | P10636 | 2/20 | 0.71 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.71 |
| ▸ | RAB9A | P51151 | 1/20 | 0.71 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.70 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.70 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.70 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.64 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.64 |
| ▸ | MMP1 | P03956 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL93664 | 0.91 | NR3C1 (0.85) | NR3C1PGRARCYP3A4HIF1A | |
| SCHEMBL3164036 | 0.91 | NR3C1 (0.85) | NR3C1PGRARCYP3A4HIF1A | |
| SCHEMBL11875376 | 0.91 | NR3C1 (0.85) | NR3C1PGRARCYP3A4HIF1A | |
| SCHEMBL11600201 | 0.91 | NR3C1 (0.85) | NR3C1PGRARCYP3A4HIF1A | |
| SCHEMBL11600203 | 0.91 | NR3C1 (0.85) | NR3C1PGRARCYP3A4HIF1A | |
| SCHEMBL11125210 | 0.91 | NR3C1 (0.85) | NR3C1PGRARCYP3A4HIF1A | |
| SCHEMBL11125211 | 0.91 | NR3C1 (0.85) | NR3C1PGRARCYP3A4HIF1A | |
| SCHEMBL8199259 | 0.89 | PGR (0.86) | NR3C1PGRARCYP3A4HIF1A | |
| SCHEMBL11289697 | 0.89 | NR3C1 (0.72) | NR3C1PGRARCYP3A4HIF1A | |
| SCHEMBL10907302 | 0.89 | PGR (0.86) | NR3C1PGRARCYP3A4HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 925 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023183932-A2 | MONOBODIES BINDING TO INTERCELLULAR ADHESION MOLECULE 2 (ICAM-2) | NEW YORK UNIVERSITY (US) | 2023-09-28 | — | — | WO | claimed |
| US-20210063375-A1 | SCREENING AND CONFIRMATION METHOD FOR VETERINARY DRUGS AND ADDITIVES IN ANIMAL-DERIVED FOOD | HENAN INST OF VETERINARY DRUG AND FEED CONTROL (CN) | 2021-03-04 | — | — | US | claimed |
| EP-2050439-B1 | PROCESS FOR PRODUCTION OF SPHERICAL GRANULE CONTAINING SLIGHTLY WATER-SOLUBLE SUBSTANCE | ASAHI CHEMICAL IND (JP) | 2016-11-23 | — | — | EP | claimed |
| CN-105263474-A | Corticosteroid compositions | TOLMAR INC | 2016-01-20 | — | — | CN | claimed |
| US-9095512-B2 | Method for producing spherical base granules comprising hardly water-soluble drug | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2015-08-04 | — | — | US | claimed |
| US-20130059814-A1 | ANTI-INFLAMMATORY DERMATOLOGICAL COMPOSITION COMPRISING CORTICOSTEROIDS AND HYALURONATE FRAGMENTS, AND USES THEREOF | CHAUMONT CHRISTINE (FR) | 2013-03-07 | — | — | US | claimed |
| US-20110275602-A1 | PHARMACEUTICAL ASSOCIATION, COMPOSITIONS FOR TOPICAL USE, FORMS OF DOSAGE AND METHOD OF TREATMENT OF ACUTE OR CHRONIC OTITIS IN PET ANIMALS | OURO FINO PARTICIPACOES E EMPREENDIMENTOS LTDA. (BR) | 2011-11-10 | — | — | US | claimed |
| US-20110230431-A1 | FOSFOMYCIN/TOBRAMYCIN COMBINATIONS FOR THE TREATMENT AND PREVENTION OF OPHTHALMIC, OTOLOGICAL AND DERMATOLOGICAL INFECTIONS | GILEAD SCIENCES, INC. (US) | 2011-09-22 | — | — | US | claimed |
| EP-2349278-A1 | FOSFOMYCIN/TOBRAMYCIN COMBINATIONS FOR THE TREATMENT AND PREVENTION OF OPHTHALMIC, OTOLOGICAL AND DERMATOLOGICAL INFECTIONS | Gilead Sciences, Inc. (US) | 2011-08-03 | — | — | EP | claimed |
| US-7887842-B2 | occluding a topically applied dermatological agent such as a steroid with a hydrogel patch mixture of a water-soluble polymer gel; water; a water retaining agent; and a cross-linking agent and does not contain a pharmaceutically active agent | TEIKOKU PHARMA USA, INC. (US) | 2011-02-15 | — | — | US | claimed |
| US-20050042173-A1 | Micronized film-forming powder comprising an active substance | BESINS INTERNATIONAL BELGIQUE (BE) | 2005-02-24 | — | — | US | claimed |
| US-20040202706-A1 | Methods of administering a dermatological agent to a subject | TEIKOKU SEIYAKU CO., LTD. (JP) | 2004-10-14 | — | — | US | claimed |
| EP-1458356-A1 | MICRONIZED PHARMACEUTICAL OR NUTRACEUTICAL POWDER WITH IMMEDIATE RELEASE | Besins International Belgique (BE) | 2004-09-22 | — | — | EP | claimed |
| EP-1450772-A1 | MICRONIZED FILM-FORMING POWDER COMPRISING AN ACTIVE SUBSTANCE | Besins International Belgique (BE) | 2004-09-01 | — | — | EP | claimed |
| WO-2004071469-A2 | METHODS OF ADMINISTERING A DERMATOLOGICAL AGENT TO A SUBJECT | TEIKOKU PHARMA USA, INC. (US) | 2004-08-26 | — | — | WO | claimed |
| US-6683070-B2 | SUSPENSION OF WATER INSOLUBLE DRUG AND WATER SOLUBLE POLYMER; REDUCING DRUG CONCENTRATION, SURFACE TENSION | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2004-01-27 | — | — | US | claimed |
| WO-2003055464-A1 | MICRONIZED PHARMACEUTICAL OR NUTRACEUTICAL POWDER WITH IMMEDIATE RELEASE | BESINS INTERNATIONAL BELGIQUE (BE) | 2003-07-10 | — | — | WO | claimed |
| US-20030124191-A1 | Use of an immediate-release powder in pharmaceutical and nutraceutical compositions | GALENIX INNOVATIONS (FR) | 2003-07-03 | — | — | US | claimed |
| WO-2003043612-A1 | MICRONIZED FILM-FORMING POWDER COMPRISING AN ACTIVE SUBSTANCE | BESINS INTERNATIONAL BELGIQUE (BE) | 2003-05-30 | — | — | WO | claimed |
| US-20030096012-A1 | Film-forming powder, compositions containing it, methods for their preparation and their uses | GALENIX INNOVATIONS (FR) | 2003-05-22 | — | — | US | claimed |